nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketorolac—PTGS2—colon cancer	0.771	1	CbGaD
Ketorolac—PTGS1—endothelium—colon cancer	0.00196	0.0984	CbGeAlD
Ketorolac—PTGS2—endothelium—colon cancer	0.00187	0.094	CbGeAlD
Ketorolac—PTGS1—blood vessel—colon cancer	0.00181	0.0907	CbGeAlD
Ketorolac—PTGS2—blood vessel—colon cancer	0.00173	0.0867	CbGeAlD
Ketorolac—PTGS2—gall bladder—colon cancer	0.00162	0.0816	CbGeAlD
Ketorolac—PTGS2—embryo—colon cancer	0.00103	0.0517	CbGeAlD
Ketorolac—Tiaprofenic acid—PTGS2—colon cancer	0.000969	0.158	CrCbGaD
Ketorolac—Nepafenac—PTGS2—colon cancer	0.000922	0.15	CrCbGaD
Ketorolac—Fenbufen—PTGS2—colon cancer	0.000882	0.143	CrCbGaD
Ketorolac—PTGS1—epithelium—colon cancer	0.000879	0.0442	CbGeAlD
Ketorolac—PTGS1—smooth muscle tissue—colon cancer	0.000847	0.0426	CbGeAlD
Ketorolac—PTGS2—epithelium—colon cancer	0.00084	0.0422	CbGeAlD
Ketorolac—PTGS1—renal system—colon cancer	0.000815	0.041	CbGeAlD
Ketorolac—PTGS2—smooth muscle tissue—colon cancer	0.000809	0.0407	CbGeAlD
Ketorolac—PTGS2—renal system—colon cancer	0.000779	0.0392	CbGeAlD
Ketorolac—Tolmetin—PTGS2—colon cancer	0.000766	0.125	CrCbGaD
Ketorolac—Salsalate—PTGS2—colon cancer	0.000766	0.125	CrCbGaD
Ketorolac—Mebendazole—ABCB1—colon cancer	0.000734	0.119	CrCbGaD
Ketorolac—Suprofen—PTGS2—colon cancer	0.000734	0.119	CrCbGaD
Ketorolac—PTGS1—digestive system—colon cancer	0.000669	0.0336	CbGeAlD
Ketorolac—PTGS2—lymphoid tissue—colon cancer	0.000647	0.0325	CbGeAlD
Ketorolac—PTGS2—digestive system—colon cancer	0.000639	0.0321	CbGeAlD
Ketorolac—PTGS1—vagina—colon cancer	0.00059	0.0297	CbGeAlD
Ketorolac—PTGS2—bone marrow—colon cancer	0.000589	0.0296	CbGeAlD
Ketorolac—PTGS2—vagina—colon cancer	0.000564	0.0284	CbGeAlD
Ketorolac—PTGS2—liver—colon cancer	0.000476	0.0239	CbGeAlD
Ketorolac—PTGS1—lymph node—colon cancer	0.000382	0.0192	CbGeAlD
Ketorolac—Ketoprofen—PTGS2—colon cancer	0.000374	0.0608	CrCbGaD
Ketorolac—PTGS2—lymph node—colon cancer	0.000365	0.0183	CbGeAlD
Ketorolac—Shock—Irinotecan—colon cancer	0.000284	0.00139	CcSEcCtD
Ketorolac—Nervous system disorder—Irinotecan—colon cancer	0.000283	0.00139	CcSEcCtD
Ketorolac—Agranulocytosis—Capecitabine—colon cancer	0.000282	0.00139	CcSEcCtD
Ketorolac—Thrombocytopenia—Irinotecan—colon cancer	0.000282	0.00139	CcSEcCtD
Ketorolac—Anorexia—Vincristine—colon cancer	0.000282	0.00139	CcSEcCtD
Ketorolac—Hyperhidrosis—Irinotecan—colon cancer	0.000279	0.00137	CcSEcCtD
Ketorolac—Confusional state—Fluorouracil—colon cancer	0.000278	0.00137	CcSEcCtD
Ketorolac—Hypotension—Vincristine—colon cancer	0.000277	0.00136	CcSEcCtD
Ketorolac—Bradycardia—Capecitabine—colon cancer	0.000276	0.00136	CcSEcCtD
Ketorolac—Anaphylactic shock—Fluorouracil—colon cancer	0.000276	0.00136	CcSEcCtD
Ketorolac—Oedema—Fluorouracil—colon cancer	0.000276	0.00136	CcSEcCtD
Ketorolac—Anorexia—Irinotecan—colon cancer	0.000275	0.00135	CcSEcCtD
Ketorolac—Infection—Fluorouracil—colon cancer	0.000274	0.00135	CcSEcCtD
Ketorolac—Haemoglobin—Capecitabine—colon cancer	0.000273	0.00134	CcSEcCtD
Ketorolac—Rhinitis—Capecitabine—colon cancer	0.000272	0.00134	CcSEcCtD
Ketorolac—Hepatitis—Capecitabine—colon cancer	0.000271	0.00134	CcSEcCtD
Ketorolac—Haemorrhage—Capecitabine—colon cancer	0.000271	0.00134	CcSEcCtD
Ketorolac—Nervous system disorder—Fluorouracil—colon cancer	0.000271	0.00133	CcSEcCtD
Ketorolac—Thrombocytopenia—Fluorouracil—colon cancer	0.00027	0.00133	CcSEcCtD
Ketorolac—Liver function test abnormal—Methotrexate—colon cancer	0.00027	0.00133	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Vincristine—colon cancer	0.00027	0.00133	CcSEcCtD
Ketorolac—Tachycardia—Fluorouracil—colon cancer	0.000269	0.00132	CcSEcCtD
Ketorolac—Hypotension—Irinotecan—colon cancer	0.000269	0.00132	CcSEcCtD
Ketorolac—Urinary tract disorder—Capecitabine—colon cancer	0.000268	0.00132	CcSEcCtD
Ketorolac—Insomnia—Vincristine—colon cancer	0.000268	0.00132	CcSEcCtD
Ketorolac—Connective tissue disorder—Capecitabine—colon cancer	0.000267	0.00131	CcSEcCtD
Ketorolac—Urethral disorder—Capecitabine—colon cancer	0.000266	0.00131	CcSEcCtD
Ketorolac—Paraesthesia—Vincristine—colon cancer	0.000266	0.00131	CcSEcCtD
Ketorolac—Breast disorder—Methotrexate—colon cancer	0.000264	0.0013	CcSEcCtD
Ketorolac—Anorexia—Fluorouracil—colon cancer	0.000263	0.00129	CcSEcCtD
Ketorolac—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000263	0.00129	CcSEcCtD
Ketorolac—Visual impairment—Capecitabine—colon cancer	0.000262	0.00129	CcSEcCtD
Ketorolac—Insomnia—Irinotecan—colon cancer	0.000261	0.00128	CcSEcCtD
Ketorolac—Paraesthesia—Irinotecan—colon cancer	0.000259	0.00127	CcSEcCtD
Ketorolac—Hypotension—Fluorouracil—colon cancer	0.000258	0.00127	CcSEcCtD
Ketorolac—Decreased appetite—Vincristine—colon cancer	0.000257	0.00127	CcSEcCtD
Ketorolac—Dyspnoea—Irinotecan—colon cancer	0.000257	0.00126	CcSEcCtD
Ketorolac—Erythema multiforme—Capecitabine—colon cancer	0.000257	0.00126	CcSEcCtD
Ketorolac—Somnolence—Irinotecan—colon cancer	0.000256	0.00126	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Vincristine—colon cancer	0.000255	0.00126	CcSEcCtD
Ketorolac—Fatigue—Vincristine—colon cancer	0.000255	0.00125	CcSEcCtD
Ketorolac—Eye disorder—Capecitabine—colon cancer	0.000254	0.00125	CcSEcCtD
Ketorolac—Dyspepsia—Irinotecan—colon cancer	0.000254	0.00125	CcSEcCtD
Ketorolac—Tinnitus—Capecitabine—colon cancer	0.000253	0.00124	CcSEcCtD
Ketorolac—Pain—Vincristine—colon cancer	0.000253	0.00124	CcSEcCtD
Ketorolac—Constipation—Vincristine—colon cancer	0.000253	0.00124	CcSEcCtD
Ketorolac—Asthma—Methotrexate—colon cancer	0.000253	0.00124	CcSEcCtD
Ketorolac—Flushing—Capecitabine—colon cancer	0.000252	0.00124	CcSEcCtD
Ketorolac—Cardiac disorder—Capecitabine—colon cancer	0.000252	0.00124	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000251	0.00124	CcSEcCtD
Ketorolac—Decreased appetite—Irinotecan—colon cancer	0.000251	0.00123	CcSEcCtD
Ketorolac—Eosinophilia—Methotrexate—colon cancer	0.00025	0.00123	CcSEcCtD
Ketorolac—Insomnia—Fluorouracil—colon cancer	0.00025	0.00123	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Irinotecan—colon cancer	0.000249	0.00122	CcSEcCtD
Ketorolac—Fatigue—Irinotecan—colon cancer	0.000248	0.00122	CcSEcCtD
Ketorolac—Paraesthesia—Fluorouracil—colon cancer	0.000248	0.00122	CcSEcCtD
Ketorolac—Pancreatitis—Methotrexate—colon cancer	0.000248	0.00122	CcSEcCtD
Ketorolac—Pain—Irinotecan—colon cancer	0.000246	0.00121	CcSEcCtD
Ketorolac—Constipation—Irinotecan—colon cancer	0.000246	0.00121	CcSEcCtD
Ketorolac—Angiopathy—Capecitabine—colon cancer	0.000246	0.00121	CcSEcCtD
Ketorolac—Dyspnoea—Fluorouracil—colon cancer	0.000246	0.00121	CcSEcCtD
Ketorolac—Somnolence—Fluorouracil—colon cancer	0.000245	0.00121	CcSEcCtD
Ketorolac—Immune system disorder—Capecitabine—colon cancer	0.000245	0.00121	CcSEcCtD
Ketorolac—Mediastinal disorder—Capecitabine—colon cancer	0.000245	0.0012	CcSEcCtD
Ketorolac—Chills—Capecitabine—colon cancer	0.000244	0.0012	CcSEcCtD
Ketorolac—Dyspepsia—Fluorouracil—colon cancer	0.000243	0.00119	CcSEcCtD
Ketorolac—Arrhythmia—Capecitabine—colon cancer	0.000243	0.00119	CcSEcCtD
Ketorolac—Gastrointestinal pain—Vincristine—colon cancer	0.000242	0.00119	CcSEcCtD
Ketorolac—Decreased appetite—Fluorouracil—colon cancer	0.00024	0.00118	CcSEcCtD
Ketorolac—Alopecia—Capecitabine—colon cancer	0.00024	0.00118	CcSEcCtD
Ketorolac—Pancytopenia—Methotrexate—colon cancer	0.00024	0.00118	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000238	0.00117	CcSEcCtD
Ketorolac—Mental disorder—Capecitabine—colon cancer	0.000238	0.00117	CcSEcCtD
Ketorolac—Feeling abnormal—Irinotecan—colon cancer	0.000237	0.00117	CcSEcCtD
Ketorolac—Erythema—Capecitabine—colon cancer	0.000236	0.00116	CcSEcCtD
Ketorolac—Malnutrition—Capecitabine—colon cancer	0.000236	0.00116	CcSEcCtD
Ketorolac—Dysuria—Methotrexate—colon cancer	0.000236	0.00116	CcSEcCtD
Ketorolac—Pain—Fluorouracil—colon cancer	0.000236	0.00116	CcSEcCtD
Ketorolac—Gastrointestinal pain—Irinotecan—colon cancer	0.000236	0.00116	CcSEcCtD
Ketorolac—Body temperature increased—Vincristine—colon cancer	0.000234	0.00115	CcSEcCtD
Ketorolac—Abdominal pain—Vincristine—colon cancer	0.000234	0.00115	CcSEcCtD
Ketorolac—Flatulence—Capecitabine—colon cancer	0.000233	0.00115	CcSEcCtD
Ketorolac—Dysgeusia—Capecitabine—colon cancer	0.000231	0.00114	CcSEcCtD
Ketorolac—Photosensitivity reaction—Methotrexate—colon cancer	0.00023	0.00113	CcSEcCtD
Ketorolac—Back pain—Capecitabine—colon cancer	0.000229	0.00112	CcSEcCtD
Ketorolac—Abdominal pain—Irinotecan—colon cancer	0.000228	0.00112	CcSEcCtD
Ketorolac—Body temperature increased—Irinotecan—colon cancer	0.000228	0.00112	CcSEcCtD
Ketorolac—Feeling abnormal—Fluorouracil—colon cancer	0.000227	0.00112	CcSEcCtD
Ketorolac—Pneumonia—Methotrexate—colon cancer	0.000226	0.00111	CcSEcCtD
Ketorolac—Drowsiness—Methotrexate—colon cancer	0.000225	0.00111	CcSEcCtD
Ketorolac—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000223	0.0011	CcSEcCtD
Ketorolac—Vision blurred—Capecitabine—colon cancer	0.000223	0.0011	CcSEcCtD
Ketorolac—Tremor—Capecitabine—colon cancer	0.000221	0.00109	CcSEcCtD
Ketorolac—Renal failure—Methotrexate—colon cancer	0.000221	0.00109	CcSEcCtD
Ketorolac—Stomatitis—Methotrexate—colon cancer	0.000219	0.00108	CcSEcCtD
Ketorolac—Ill-defined disorder—Capecitabine—colon cancer	0.000219	0.00108	CcSEcCtD
Ketorolac—Urticaria—Fluorouracil—colon cancer	0.000219	0.00108	CcSEcCtD
Ketorolac—Conjunctivitis—Methotrexate—colon cancer	0.000219	0.00108	CcSEcCtD
Ketorolac—Anaemia—Capecitabine—colon cancer	0.000218	0.00107	CcSEcCtD
Ketorolac—Body temperature increased—Fluorouracil—colon cancer	0.000218	0.00107	CcSEcCtD
Ketorolac—Hypersensitivity—Vincristine—colon cancer	0.000218	0.00107	CcSEcCtD
Ketorolac—Sweating—Methotrexate—colon cancer	0.000216	0.00106	CcSEcCtD
Ketorolac—Haematuria—Methotrexate—colon cancer	0.000215	0.00106	CcSEcCtD
Ketorolac—Malaise—Capecitabine—colon cancer	0.000213	0.00105	CcSEcCtD
Ketorolac—Hepatobiliary disease—Methotrexate—colon cancer	0.000213	0.00105	CcSEcCtD
Ketorolac—Epistaxis—Methotrexate—colon cancer	0.000212	0.00104	CcSEcCtD
Ketorolac—Vertigo—Capecitabine—colon cancer	0.000212	0.00104	CcSEcCtD
Ketorolac—Hypersensitivity—Irinotecan—colon cancer	0.000212	0.00104	CcSEcCtD
Ketorolac—Asthenia—Vincristine—colon cancer	0.000212	0.00104	CcSEcCtD
Ketorolac—Syncope—Capecitabine—colon cancer	0.000212	0.00104	CcSEcCtD
Ketorolac—Leukopenia—Capecitabine—colon cancer	0.000212	0.00104	CcSEcCtD
Ketorolac—Agranulocytosis—Methotrexate—colon cancer	0.00021	0.00103	CcSEcCtD
Ketorolac—Palpitations—Capecitabine—colon cancer	0.000209	0.00103	CcSEcCtD
Ketorolac—Loss of consciousness—Capecitabine—colon cancer	0.000208	0.00102	CcSEcCtD
Ketorolac—Asthenia—Irinotecan—colon cancer	0.000207	0.00102	CcSEcCtD
Ketorolac—Cough—Capecitabine—colon cancer	0.000206	0.00101	CcSEcCtD
Ketorolac—Hypertension—Capecitabine—colon cancer	0.000204	0.001	CcSEcCtD
Ketorolac—Hypersensitivity—Fluorouracil—colon cancer	0.000203	0.001	CcSEcCtD
Ketorolac—Haemoglobin—Methotrexate—colon cancer	0.000203	0.000999	CcSEcCtD
Ketorolac—Diarrhoea—Vincristine—colon cancer	0.000202	0.000996	CcSEcCtD
Ketorolac—Haemorrhage—Methotrexate—colon cancer	0.000202	0.000994	CcSEcCtD
Ketorolac—Hepatitis—Methotrexate—colon cancer	0.000202	0.000994	CcSEcCtD
Ketorolac—Arthralgia—Capecitabine—colon cancer	0.000201	0.00099	CcSEcCtD
Ketorolac—Chest pain—Capecitabine—colon cancer	0.000201	0.00099	CcSEcCtD
Ketorolac—Myalgia—Capecitabine—colon cancer	0.000201	0.00099	CcSEcCtD
Ketorolac—Anxiety—Capecitabine—colon cancer	0.000201	0.000986	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.0002	0.000983	CcSEcCtD
Ketorolac—Urinary tract disorder—Methotrexate—colon cancer	0.0002	0.000982	CcSEcCtD
Ketorolac—Discomfort—Capecitabine—colon cancer	0.000199	0.000978	CcSEcCtD
Ketorolac—Urethral disorder—Methotrexate—colon cancer	0.000198	0.000974	CcSEcCtD
Ketorolac—Diarrhoea—Irinotecan—colon cancer	0.000197	0.00097	CcSEcCtD
Ketorolac—Dry mouth—Capecitabine—colon cancer	0.000197	0.000968	CcSEcCtD
Ketorolac—Dizziness—Vincristine—colon cancer	0.000196	0.000962	CcSEcCtD
Ketorolac—Pruritus—Fluorouracil—colon cancer	0.000195	0.00096	CcSEcCtD
Ketorolac—Visual impairment—Methotrexate—colon cancer	0.000195	0.000958	CcSEcCtD
Ketorolac—Confusional state—Capecitabine—colon cancer	0.000194	0.000957	CcSEcCtD
Ketorolac—Oedema—Capecitabine—colon cancer	0.000193	0.000949	CcSEcCtD
Ketorolac—Infection—Capecitabine—colon cancer	0.000192	0.000942	CcSEcCtD
Ketorolac—Erythema multiforme—Methotrexate—colon cancer	0.000191	0.00094	CcSEcCtD
Ketorolac—Dizziness—Irinotecan—colon cancer	0.000191	0.000937	CcSEcCtD
Ketorolac—Shock—Capecitabine—colon cancer	0.00019	0.000933	CcSEcCtD
Ketorolac—Nervous system disorder—Capecitabine—colon cancer	0.000189	0.00093	CcSEcCtD
Ketorolac—Eye disorder—Methotrexate—colon cancer	0.000189	0.000929	CcSEcCtD
Ketorolac—Diarrhoea—Fluorouracil—colon cancer	0.000189	0.000929	CcSEcCtD
Ketorolac—Thrombocytopenia—Capecitabine—colon cancer	0.000189	0.000929	CcSEcCtD
Ketorolac—Tinnitus—Methotrexate—colon cancer	0.000188	0.000927	CcSEcCtD
Ketorolac—Tachycardia—Capecitabine—colon cancer	0.000188	0.000926	CcSEcCtD
Ketorolac—Vomiting—Vincristine—colon cancer	0.000188	0.000925	CcSEcCtD
Ketorolac—Cardiac disorder—Methotrexate—colon cancer	0.000188	0.000923	CcSEcCtD
Ketorolac—Skin disorder—Capecitabine—colon cancer	0.000187	0.000921	CcSEcCtD
Ketorolac—Rash—Vincristine—colon cancer	0.000187	0.000918	CcSEcCtD
Ketorolac—Hyperhidrosis—Capecitabine—colon cancer	0.000186	0.000917	CcSEcCtD
Ketorolac—Dermatitis—Vincristine—colon cancer	0.000186	0.000917	CcSEcCtD
Ketorolac—Headache—Vincristine—colon cancer	0.000185	0.000912	CcSEcCtD
Ketorolac—Anorexia—Capecitabine—colon cancer	0.000184	0.000904	CcSEcCtD
Ketorolac—Angiopathy—Methotrexate—colon cancer	0.000183	0.000902	CcSEcCtD
Ketorolac—Vomiting—Irinotecan—colon cancer	0.000183	0.000901	CcSEcCtD
Ketorolac—Immune system disorder—Methotrexate—colon cancer	0.000183	0.000898	CcSEcCtD
Ketorolac—Dizziness—Fluorouracil—colon cancer	0.000183	0.000898	CcSEcCtD
Ketorolac—Mediastinal disorder—Methotrexate—colon cancer	0.000182	0.000896	CcSEcCtD
Ketorolac—Rash—Irinotecan—colon cancer	0.000182	0.000894	CcSEcCtD
Ketorolac—Dermatitis—Irinotecan—colon cancer	0.000182	0.000893	CcSEcCtD
Ketorolac—Chills—Methotrexate—colon cancer	0.000181	0.000892	CcSEcCtD
Ketorolac—Headache—Irinotecan—colon cancer	0.000181	0.000888	CcSEcCtD
Ketorolac—Hypotension—Capecitabine—colon cancer	0.00018	0.000886	CcSEcCtD
Ketorolac—Alopecia—Methotrexate—colon cancer	0.000179	0.000878	CcSEcCtD
Ketorolac—Mental disorder—Methotrexate—colon cancer	0.000177	0.000871	CcSEcCtD
Ketorolac—Erythema—Methotrexate—colon cancer	0.000176	0.000865	CcSEcCtD
Ketorolac—Malnutrition—Methotrexate—colon cancer	0.000176	0.000865	CcSEcCtD
Ketorolac—Nausea—Vincristine—colon cancer	0.000176	0.000865	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000176	0.000864	CcSEcCtD
Ketorolac—Vomiting—Fluorouracil—colon cancer	0.000176	0.000863	CcSEcCtD
Ketorolac—Insomnia—Capecitabine—colon cancer	0.000174	0.000858	CcSEcCtD
Ketorolac—Rash—Fluorouracil—colon cancer	0.000174	0.000856	CcSEcCtD
Ketorolac—Dermatitis—Fluorouracil—colon cancer	0.000174	0.000855	CcSEcCtD
Ketorolac—Paraesthesia—Capecitabine—colon cancer	0.000173	0.000852	CcSEcCtD
Ketorolac—Headache—Fluorouracil—colon cancer	0.000173	0.00085	CcSEcCtD
Ketorolac—Dysgeusia—Methotrexate—colon cancer	0.000172	0.000847	CcSEcCtD
Ketorolac—Dyspnoea—Capecitabine—colon cancer	0.000172	0.000846	CcSEcCtD
Ketorolac—Nausea—Irinotecan—colon cancer	0.000171	0.000842	CcSEcCtD
Ketorolac—Back pain—Methotrexate—colon cancer	0.00017	0.000837	CcSEcCtD
Ketorolac—Dyspepsia—Capecitabine—colon cancer	0.00017	0.000835	CcSEcCtD
Ketorolac—Decreased appetite—Capecitabine—colon cancer	0.000168	0.000825	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Capecitabine—colon cancer	0.000167	0.000819	CcSEcCtD
Ketorolac—Fatigue—Capecitabine—colon cancer	0.000166	0.000818	CcSEcCtD
Ketorolac—Vision blurred—Methotrexate—colon cancer	0.000166	0.000815	CcSEcCtD
Ketorolac—Pain—Capecitabine—colon cancer	0.000165	0.000811	CcSEcCtD
Ketorolac—Constipation—Capecitabine—colon cancer	0.000165	0.000811	CcSEcCtD
Ketorolac—Nausea—Fluorouracil—colon cancer	0.000164	0.000806	CcSEcCtD
Ketorolac—Ill-defined disorder—Methotrexate—colon cancer	0.000163	0.000803	CcSEcCtD
Ketorolac—Anaemia—Methotrexate—colon cancer	0.000163	0.0008	CcSEcCtD
Ketorolac—Feeling abnormal—Capecitabine—colon cancer	0.000159	0.000782	CcSEcCtD
Ketorolac—Malaise—Methotrexate—colon cancer	0.000159	0.00078	CcSEcCtD
Ketorolac—Vertigo—Methotrexate—colon cancer	0.000158	0.000777	CcSEcCtD
Ketorolac—Gastrointestinal pain—Capecitabine—colon cancer	0.000158	0.000776	CcSEcCtD
Ketorolac—Leukopenia—Methotrexate—colon cancer	0.000157	0.000775	CcSEcCtD
Ketorolac—Cough—Methotrexate—colon cancer	0.000154	0.000755	CcSEcCtD
Ketorolac—Urticaria—Capecitabine—colon cancer	0.000153	0.000754	CcSEcCtD
Ketorolac—Abdominal pain—Capecitabine—colon cancer	0.000152	0.00075	CcSEcCtD
Ketorolac—Body temperature increased—Capecitabine—colon cancer	0.000152	0.00075	CcSEcCtD
Ketorolac—Convulsion—Methotrexate—colon cancer	0.000152	0.00075	CcSEcCtD
Ketorolac—Chest pain—Methotrexate—colon cancer	0.00015	0.000737	CcSEcCtD
Ketorolac—Myalgia—Methotrexate—colon cancer	0.00015	0.000737	CcSEcCtD
Ketorolac—Arthralgia—Methotrexate—colon cancer	0.00015	0.000737	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000149	0.000732	CcSEcCtD
Ketorolac—Discomfort—Methotrexate—colon cancer	0.000148	0.000728	CcSEcCtD
Ketorolac—Confusional state—Methotrexate—colon cancer	0.000145	0.000712	CcSEcCtD
Ketorolac—Anaphylactic shock—Methotrexate—colon cancer	0.000144	0.000706	CcSEcCtD
Ketorolac—Infection—Methotrexate—colon cancer	0.000143	0.000702	CcSEcCtD
Ketorolac—Hypersensitivity—Capecitabine—colon cancer	0.000142	0.000699	CcSEcCtD
Ketorolac—Nervous system disorder—Methotrexate—colon cancer	0.000141	0.000693	CcSEcCtD
Ketorolac—Thrombocytopenia—Methotrexate—colon cancer	0.000141	0.000691	CcSEcCtD
Ketorolac—Skin disorder—Methotrexate—colon cancer	0.000139	0.000686	CcSEcCtD
Ketorolac—Hyperhidrosis—Methotrexate—colon cancer	0.000139	0.000683	CcSEcCtD
Ketorolac—Asthenia—Capecitabine—colon cancer	0.000138	0.000681	CcSEcCtD
Ketorolac—Anorexia—Methotrexate—colon cancer	0.000137	0.000673	CcSEcCtD
Ketorolac—Pruritus—Capecitabine—colon cancer	0.000136	0.000671	CcSEcCtD
Ketorolac—Hypotension—Methotrexate—colon cancer	0.000134	0.00066	CcSEcCtD
Ketorolac—Diarrhoea—Capecitabine—colon cancer	0.000132	0.000649	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000131	0.000643	CcSEcCtD
Ketorolac—Insomnia—Methotrexate—colon cancer	0.00013	0.000639	CcSEcCtD
Ketorolac—Paraesthesia—Methotrexate—colon cancer	0.000129	0.000634	CcSEcCtD
Ketorolac—Dyspnoea—Methotrexate—colon cancer	0.000128	0.00063	CcSEcCtD
Ketorolac—Somnolence—Methotrexate—colon cancer	0.000128	0.000628	CcSEcCtD
Ketorolac—Dizziness—Capecitabine—colon cancer	0.000128	0.000627	CcSEcCtD
Ketorolac—Dyspepsia—Methotrexate—colon cancer	0.000126	0.000622	CcSEcCtD
Ketorolac—Decreased appetite—Methotrexate—colon cancer	0.000125	0.000614	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Methotrexate—colon cancer	0.000124	0.00061	CcSEcCtD
Ketorolac—Fatigue—Methotrexate—colon cancer	0.000124	0.000609	CcSEcCtD
Ketorolac—Pain—Methotrexate—colon cancer	0.000123	0.000604	CcSEcCtD
Ketorolac—Vomiting—Capecitabine—colon cancer	0.000123	0.000603	CcSEcCtD
Ketorolac—Rash—Capecitabine—colon cancer	0.000122	0.000598	CcSEcCtD
Ketorolac—Dermatitis—Capecitabine—colon cancer	0.000122	0.000598	CcSEcCtD
Ketorolac—Headache—Capecitabine—colon cancer	0.000121	0.000594	CcSEcCtD
Ketorolac—Feeling abnormal—Methotrexate—colon cancer	0.000118	0.000582	CcSEcCtD
Ketorolac—Gastrointestinal pain—Methotrexate—colon cancer	0.000117	0.000577	CcSEcCtD
Ketorolac—Nausea—Capecitabine—colon cancer	0.000115	0.000563	CcSEcCtD
Ketorolac—Urticaria—Methotrexate—colon cancer	0.000114	0.000561	CcSEcCtD
Ketorolac—Abdominal pain—Methotrexate—colon cancer	0.000114	0.000558	CcSEcCtD
Ketorolac—Body temperature increased—Methotrexate—colon cancer	0.000114	0.000558	CcSEcCtD
Ketorolac—Hypersensitivity—Methotrexate—colon cancer	0.000106	0.00052	CcSEcCtD
Ketorolac—Asthenia—Methotrexate—colon cancer	0.000103	0.000507	CcSEcCtD
Ketorolac—Pruritus—Methotrexate—colon cancer	0.000102	0.0005	CcSEcCtD
Ketorolac—Diarrhoea—Methotrexate—colon cancer	9.82e-05	0.000483	CcSEcCtD
Ketorolac—Dizziness—Methotrexate—colon cancer	9.5e-05	0.000467	CcSEcCtD
Ketorolac—Vomiting—Methotrexate—colon cancer	9.13e-05	0.000449	CcSEcCtD
Ketorolac—Rash—Methotrexate—colon cancer	9.05e-05	0.000445	CcSEcCtD
Ketorolac—Dermatitis—Methotrexate—colon cancer	9.05e-05	0.000445	CcSEcCtD
Ketorolac—Headache—Methotrexate—colon cancer	9e-05	0.000442	CcSEcCtD
Ketorolac—Nausea—Methotrexate—colon cancer	8.53e-05	0.000419	CcSEcCtD
